FDA Adverse Event Injury Summary report: N

QUADRA-H CEMENTLESS, HA COATED STEM SIZE 4 LAT

MDR report key: 6352736 · Received February 23, 2017

Report

Report Number
3005180920-2017-00064
Event Type
Injury
Date Received
February 23, 2017
Date of Event
January 24, 2017
Report Date
February 23, 2017
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
JDI
PMA / PMN Number
K082792
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION RECEIVED ON 31 JANUARY 2017 AND INCLUDES: ALL OTHER ITEMS ARE NON-MEDACTA PRODUCTS. ON 10 FEBRUARY 2017 THE MEDICAL AFFAIRS DIRECTOR PERFORMED A CLINICAL EVALUATION AND COMMENTED AS FOLLOWS: TOTAL REVISION OF A CEMENTLESS THA PERFORMED ON A MALE PATIENT, 7 YEARS AFTER PRIMARY SURGERY. IN THE PRIMARY CASE, A LARGE DIAMETER METAL HEAD, NOT MANUFACTURED BY MEDACTA, WAS USED ON A MEDACTA STEM IN COMBINATION WITH A NON-MEDACTA, UNKNOWN MONOBLOCK METAL CUP. ACCORDING TO REPORT, THE CAUSE FOR REVISION IS OSTEOLYSIS (VISIBLE ON THE X-RAY) CAUSED BY METALLOSIS. THE METALLOSIS EFFECT IS MOST LIKELY ORIGINATED AT THE TRIBOLOGICAL INTERFACE BETWEEN HEAD AND CUP. THE STEM SHOULD NOT BE CONSIDERED RESPONSIBLE FOR THIS ADVERSE EVENT. ADDITIONAL INFORMATION RECEIVED ON 17 FEBRUARY 2017 AND INCLUDES: THE SURGEON LEFT THE STEM IN PLACE AND REVISED HEAD AND LINER. THE SURGERY WAS COMPLETED SUCCESSFULLY. BATCH REVIEW PERFORMED ON 21 FEBRUARY 2017. LOT 090625: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 14 MAY 2009. EXPIRATION DATE: 2014-04-30. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

THE SURGEON DETERMINED THE PATIENT HAD METALLOSIS AND PLANNED TO REVISE THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
134933 QUADRA-H CEMENTLESS, HA COATED STEM SIZE 4 LAT CEMENTLESS FEMORAL STEM JDI MEDACTA INTERNATIONAL SA 090625

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention